Disulfidptosis-related lncRNA signature to assess the immune microenvironment and drug sensitivity in acute myeloid leukemia
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
researchers have identified a disulfidptosis-related lncrna signature that may be used to assess the immune microenvironment and drug sensitivity in acute myeloid leukemia. this signature could potentially provide new insights into the disease. the discovery may have implications for understanding and treating acute myeloid leukemia.